National Institute on Drug Abuse (NIDA)
www.nida.nih.gov
The mission of the National Institute on Drug
Abuse (NIDA) is to lead the nation in bringing
the power of science to bear on drug abuse and
addiction. Recent scientific advances have revolutionized
our understanding of drug abuse and addiction.
The majority of these advances, which have dramatic
implications for how to best prevent and treat
addiction, have been supported by NIDA. NIDA supports
over 85 percent of the world's research on the
health aspects of drug abuse and addiction. NIDA-supported
science addresses the most fundamental and essential
questions about drug abuse, ranging from the molecule
to managed care, and from DNA to community outreach
research.
NIDA not only seizes upon unprecedented opportunities
and technologies to further understand how drugs
of abuse affect the brain and behavior, but also
works to ensure the rapid and effective transfer
of scientific data to policymakers, drug abuse
practitioners, other healthcare practitioners,
and the general public. NIDA's Web site is an
important part of this effort. The scientific
knowledge that is generated through NIDA research
is a critical element to improving the overall
national health. NIDA's goal is to ensure that
science, not ideology or anecdote, forms the foundation
for all of our nation's drug abuse reduction efforts.
Top
Substance
Abuse and Mental Health Services Administration:
Center for Substance Abuse Treatment: Division
of Pharmacologic Therapies
http://dpt.samhsa.gov/
The Substance Abuse and Mental Health Services
Administration (SAMHSA), Center for Substance
Abuse Treatment (CSAT) is engaged with treatment
experts, state and other Federal officials, and
patient representatives to develop guidelines
and other educational materials on the use of
medications such as methadone and levo-alpha-acetyl-methadol
(LAAM), and alternative therapies in the treatment
of addictions. CSAT's Division of Pharmacologic
Therapies (DPT) manages the day-to-day regulatory
oversight activities necessary to implement new
SAMHSA regulations (42 CFR Part 8) on the use
of opioid agonist medications (methadone and LAAM)
approved by the U.S. Food and Drug Administration
(FDA) for addiction treatment. These activities
include supporting the certification and accreditation
of opioid treatment programs. DPT also supports
the training of medical and substance abuse professionals
on a variety of treatment issues, including the
use of new medications, such as buprenorphine,
that are anticipated to be approved by FDA for
use by physicians.
Top
Substance Abuse and Mental Health Services Administration:
Substance Abuse Treatment Facility Locator
http://findtreatment.samhsa.gov/
This searchable directory of drug and alcohol
treatment programs shows the location of facilities
around the country that treat alcoholism, alcohol
abuse, and drug abuse problems.
The locator includes more than 11,000 addiction
treatment programs, including residential treatment
centers, outpatient treatment programs, and hospital
inpatient programs for drug addiction and alcoholism.
Listings include treatment programs for marijuana,
cocaine, and heroin addiction, as well as drug
and alcohol treatment programs for adolescents
and adults.
SAMHSA endeavors to keep the locator current.
All information in the locator is completely updated
each year, based on facility responses to SAMHSA's
National Survey of Substance Abuse Treatment Services.
New facilities are added monthly. |
